 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 October 1993 | Volume 119 Issue 8 | Pages 771-778
Objective: To determine whether plasma tumor necrosis factor-
Design: Prospective study comparing patients with the sepsis syndrome, critically ill patients without sepsis, and normal healthy volunteers.
Setting: Tertiary care hospital affiliated with a medical school.
Patients: The study included 97 consecutive patients on a medical service who met the criteria for the sepsis syndrome; 20 critically ill patients without sepsis who were in the medical intensive care unit; and 20 healthy volunteers who served as comparison groups.
Measurements: Plasma tumor necrosis factor-
Results: Fifty-four percent of patients with the sepsis syndrome had detectable levels of TNF-
Conclusions: Patients with the sepsis syndrome have detectable levels of circulating TNF-
Author and Article Information
From Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
ARTICLE
Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome
(TNF-), interleukin-1 ß (IL-1 ß), interleukin-6 (IL-6), and lipopolysaccharide are detectable in patients when they first present with the sepsis syndrome and to determine whether levels correlate with patient survival. , IL-1 ß, interleukin-6, and endotoxin (lipopolysaccharide) levels were measured when a patient was first identified as having the sepsis syndrome. Survival was defined as being alive 30 days after the sepsis syndrome was diagnosed. (median, 26 pg/mL; range, nondetectable to 1000 pg/mL); 37% had detectable levels of IL-1 (median, 20 pg/mL; range, nondetectable to 2850 pg/mL); 80% had detectable levels of IL-6 (median, 415 pg/mL; range, nondetectable to 2380 pg/mL); and 89% had detectable levels of lipopolysaccharide (median, 2.6; range, nondetectable to 12.5 endotoxin units [EU]/mL). In all cases, levels were higher than those in critically ill patients without sepsis and normal healthy controls (P < 0.001 for all comparisons). Plasma levels of TNF-, IL-1 ß, IL-6, and lipopolysaccharide were detectable in patients regardless of culture status. The IL-6 level was 69% (95% CI, 30% to 108%) higher in patients who died compared with those who survived. The scores for the individual levels of TNF-, IL-1 ß, IL-6, and lipopolysaccharide were summed to arrive at a total lipopolysaccharide-cytokine score, and mortality increased with lipopolysaccharide-cytokine score (P < 0.001). , IL-1, IL-6, and lipopolysaccharide independent of culture-documented infection. Lipopolysaccharide and cytokines may play a pathogenic role in sepsis, and the combination of several elevated factors may be important in determining patient survival.
Requests for Reprints: Larry C. Casey, MD, PhD, Rush-Presbyterian-St. Luke's Medical Center, Department of Pulmonary and Critical Care Medicine, 1725 West Harrison Street, Suite 306, Chicago, IL 60612.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  L. B. Kidd, G. A. Schabbauer, J. P. Luyendyk, T. D. Holscher, R. E. Tilley, M. Tencati, and N. Mackma Insulin Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B (Akt) Pathway Reduces Lipopolysaccharide-Induced Inflammation in Mice J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yende, G. D'Angelo, J. A. Kellum, L. Weissfeld, J. Fine, R. D. Welch, L. Kong, M. Carter, D. C. Angus, and for the GenIMS Investigators Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1242 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Marshall Sepsis: rethinking the approach to clinical research J. Leukoc. Biol., March 1, 2008; 83(3): 471 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nolan, M. Weiden, A. Kelly, Y. Hoshino, S. Hoshino, N. Mehta, and J. A. Gold CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ishii, H. Hamamoto, M. Kamimura, and K. Sekimizu Activation of the Silkworm Cytokine by Bacterial and Fungal Cell Wall Components via a Reactive Oxygen Species-triggered Mechanism J. Biol. Chem., January 25, 2008; 283(4): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Beilin, Y. Rusabrov, Y. Shapira, L. Roytblat, L. Greemberg, I. Z. Yardeni, and H. Bessler Low-dose ketamine affects immune responses in humans during the early postoperative period Br. J. Anaesth., October 1, 2007; 99(4): 522 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chatterjee, C. Dimitropoulou, F. Drakopanayiotakis, G. Antonova, C. Snead, J. Cannon, R. C. Venema, and J. D. Catravas Heat Shock Protein 90 Inhibitors Prolong Survival, Attenuate Inflammation, and Reduce Lung Injury in Murine Sepsis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, and J. W. M. van der Meer Continuous administration of PBP-2- and PBP-3-specific {beta}-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis J. Antimicrob. Chemother., May 1, 2007; 59(5): 926 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, L. Zhi, S. Moochhala, P. K. Moore, and M. Bhatia Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-{kappa}B Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L960 - L971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rios-Santos, J. C. Alves-Filho, F. O. Souto, F. Spiller, A. Freitas, C. M. C. Lotufo, M. B. P. Soares, R. R. dos Santos, M. M. Teixeira, and F. de Queiroz Cunha Down-regulation of CXCR2 on Neutrophils in Severe Sepsis Is Mediated by Inducible Nitric Oxide Synthase-derived Nitric Oxide Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 490 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sarkar, M. W. Hall, M. Exline, J. Hart, N. Knatz, N. T. Gatson, and M. D. Wewers Caspase-1 Regulates Escherichia coli Sepsis and Splenic B Cell Apoptosis Independently of Interleukin-1beta and Interleukin-18 Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kofoed, U. V. Schneider, T. Scheel, O. Andersen, and J. Eugen-Olsen Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology Clin. Chem., July 1, 2006; 52(7): 1284 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jia, M. Takahashi, H. Morimoto, S. Takahashi, A. Izawa, H. Ise, T. Iwasaki, H. Hattori, K.-J. Wu, and U. Ikeda Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors Cardiovasc Res, February 1, 2006; 69(2): 545 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Parikh, E. Abraham, M. Ancukiewicz, C. L. Edelstein, and for the Acute Respiratory Distress Syndrome (ARDS) Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3046 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Di Cesare, E. Chang, C. F. Preston, and C.-j. Liu Serum Interleukin-6 as a Marker of Periprosthetic Infection Following Total Hip and Knee Arthroplasty J. Bone Joint Surg. Am., September 1, 2005; 87(9): 1921 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nooteboom, C. J. van der Linden, and T. Hendriks Whole blood-mediated endothelial permeability and adhesion molecule expression: a model study into the effects of bacteria and antibiotics J. Antimicrob. Chemother., February 1, 2005; 55(2): 150 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Leon, D. A. DuBose, and C. W. Mason Heat stress induces a biphasic thermoregulatory response in mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R197 - R204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iwamura, M. Sato, and K. Wakitani Comparative Study of Glucocorticoids, Cyclosporine A, and JTE-607 [(-)-Ethyl-N-{3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl}-L-phenylalaninate Dihydrochloride] in a Mouse Septic Shock Model J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1256 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Y. Davani, D. R. Dorscheid, C.-H. Lee, C. van Breemen, and K. R. Walley Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1013 - H1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lake, J. DeLeo, F. Cerasoli, L. Logdberg, M. Weetall, and D. Handley Pharmacodynamic Evaluation of the Neutralization of Endotoxin by PMX622 in Mice Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2987 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gibot and A. Cravoisy Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 as a Marker of Microbial Infection Clin. Med. Res., August 1, 2004; 2(3): 181 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance Am J Physiol Cell Physiol, August 1, 2004; 287(2): C548 - C557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Duncan, L. Tiberio, and J. H. Eldridge Multivariate Analysis of Cytokine Responses Identifies Distinctive Sensitivities to Lipopolysaccharide in Humans Infect. Immun., July 1, 2004; 72(7): 4282 - 4285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Brown, M. Q. Stewart, S. A. Bissonnette, A. E. H. Elia, E. Wilker, and M. B. Yaffe Distinct Ligand-dependent Roles for p38 MAPK in Priming and Activation of the Neutrophil NADPH Oxidase J. Biol. Chem., June 25, 2004; 279(26): 27059 - 27068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Papadakos and J. J. Haitsma Cytokines: The Tomb Markers of the ICU Chest, June 1, 2004; 125(6): 1980 - 1982. [Full Text] [PDF]
|
|
|
|
|
|
I. De Freitas, M. Fernandez-Somoza, E. Essenfeld-Sekler, and J. E. Cardier Serum Levels of the Apoptosis-Associated Molecules, Tumor Necrosis Factor-{alpha}/Tumor Necrosis Factor Type-I Receptor and Fas/FasL, in Sepsis Chest, June 1, 2004; 125(6): 2238 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malagarie-Cazenave, B. Segui, S. Leveque, V. Garcia, S. Carpentier, M.-F. Altie, A. Brouchet, V. Gouaze, N. Andrieu-Abadie, Y. Barreira, et al. Role of FAN in Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-induced Interleukin-6 Secretion and Lethality in D-Galactosamine-sensitized Mice J. Biol. Chem., April 30, 2004; 279(18): 18648 - 18655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Amoureux, E. Hegyi, D. Le, P. Grandics, H. Tong, and S. Szathmary A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients Innate Immunity, April 1, 2004; 10(2): 85 - 95. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Sprong, M. G. Netea, P. van der Ley, T. J. G. Verver-Jansen, L. E. H. Jacobs, A. Stalenhoef, J. W. M. van der Meer, and M. van Deuren Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria J. Lipid Res., April 1, 2004; 45(4): 742 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Taniguchi, H. Kanakura, Y. Takemoto, and K. Yamamoto The Antiinflammatory Effects of Ketamine in Endotoxemic Rats During Moderate and Mild Hypothermia Anesth. Analg., April 1, 2004; 98(4): 1114 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Clatworthy and K. G.C. Smith Fc{gamma}RIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis J. Exp. Med., March 1, 2004; 199(5): 717 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lekkou, M. Karakantza, A. Mouzaki, F. Kalfarentzos, and C. A. Gogos Cytokine Production and Monocyte HLA-DR Expression as Predictors of Outcome for Patients with Community-Acquired Severe Infections Clin. Vaccine Immunol., January 1, 2004; 11(1): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Matsukawa, K. Takeda, S. Kudo, T. Maeda, M. Kagayama, and S. Akira Aberrant Inflammation and Lethality to Septic Peritonitis in Mice Lacking STAT3 in Macrophages and Neutrophils J. Immunol., December 1, 2003; 171(11): 6198 - 6205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Nwariaku, P. Rothenbach, Z. Liu, X. Zhu, R. H. Turnage, and L. S. Terada Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability J Appl Physiol, November 1, 2003; 95(5): 1889 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. d. J. Arana, M. G. Vallespi, G. Chinea, G. V. Vallespi, I. Rodriguez-Alonso, H. E. Garay, W. A. Buurman, and O. Reyes Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction Innate Immunity, October 1, 2003; 9(5): 281 - 291. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Mesotten, G. Van den Berghe, C. Liddle, S. Coulter, F. McDougall, R. C. Baxter, and P. J. D. Delhanty Growth Hormone Modulation of the Rat Hepatic Bile Transporter System in Endotoxin-Induced Cholestasis Endocrinology, September 1, 2003; 144(9): 4008 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Sallenave, G. A. Cunningham, R. M. James, G. McLachlan, and C. Haslett Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin Infect. Immun., July 1, 2003; 71(7): 3766 - 3774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morgera, D. Klonower, J. Rocktaschel, M. Haase, F. Priem, S. Ziemer, B. Wegner, H. Gohl, and H.-H. Neumayer TNF-{alpha} elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1361 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. A. Lobo, F. R. M. Lobo, D. P. Bota, F. Lopes-Ferreira, H. M. Soliman, C. Melot, and J.-L. Vincent C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patients Chest, June 1, 2003; 123(6): 2043 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Kvalsvig and D J Unsworth The immunopathogenesis of meningococcal disease J. Clin. Pathol., June 1, 2003; 56(6): 417 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Christoforidis, P.-G. Chassot, F. Mosimann, D. Lienard, F. Brunstein, D. Bejko, F. J. Lejeune, and R. Chiolero Isolated Limb Perfusion: Distinct Tourniquet and Tumor Necrosis Factor Effects on the Early Hemodynamic Response Arch Surg, January 1, 2003; 138(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Riedemann, T. A. Neff, R.-F. Guo, K. D. Bernacki, I. J. Laudes, J. V. Sarma, J. D. Lambris, and P. A. Ward Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression J. Immunol., January 1, 2003; 170(1): 503 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Opal The clinical relevance of endotoxin in human sepsis: a critical analysis Innate Immunity, December 1, 2002; 8(6): 473 - 476. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Knuefermann, S. Nemoto, A. Misra, N. Nozaki, G. Defreitas, S. M. Goyert, B. A. Carabello, D. L. Mann, and J. G. Vallejo CD14-Deficient Mice Are Protected Against Lipopolysaccharide-Induced Cardiac Inflammation and Left Ventricular Dysfunction Circulation, November 12, 2002; 106(20): 2608 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Moretti, B. Basso, L. Cervetta, A. Brigada, and G. Barbieri Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease Clin. Vaccine Immunol., November 1, 2002; 9(6): 1324 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zilberstein, R. Levy, M. Rachinsky, A. Fisher, L. Greemberg, Y. Shapira, A. Appelbaum, and L. Roytblat Ketamine Attenuates Neutrophil Activation After Cardiopulmonary Bypass Anesth. Analg., September 1, 2002; 95(3): 531 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J Bruins, P. B Soeters, W. H Lamers, and N. E. Deutz L-Arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia Am. J. Clinical Nutrition, June 1, 2002; 75(6): 1031 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.K. Tegtmeyer, J. Moller, and P. Zabel Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS Eur. Respir. J., April 1, 2002; 19(4): 776 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Knuefermann, S. Nemoto, G. Baumgarten, A. Misra, N. Sivasubramanian, B. A. Carabello, and J. G. Vallejo Cardiac Inflammation and Innate Immunity in Septic Shock* : Is There a Role for Toll-Like Receptors? Chest, April 1, 2002; 121(4): 1329 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. O'Neal, N. Brown, and C. Munro Physiologic Factors Contributing to a Transition in Oral Immunity among Mechanically Ventilated Adults Biol Res Nurs, January 1, 2002; 3(3): 132 - 139. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Sweet, C. C. Campbell, D. P. Sester, D. Xu, R. C. McDonald, K. J. Stacey, D. A. Hume, and F. Y. Liew Colony-Stimulating Factor-1 Suppresses Responses to CpG DNA and Expression of Toll-Like Receptor 9 but Enhances Responses to Lipopolysaccharide in Murine Macrophages J. Immunol., January 1, 2002; 168(1): 392 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. J. Groeneveld, A. W. J. Bossink, G. J. van Mierlo, and C. E. Hack Circulating Inflammatory Mediators in Patients with Fever: Predicting Bloodstream Infection Clin. Vaccine Immunol., November 1, 2001; 8(6): 1189 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. GLYNNE, J. PICOT, and T. J. EVANS Coexpressed Nitric Oxide Synthase and Apical {beta}1 Integrins Influence Tubule Cell Adhesion after Cytokine-Induced Injury J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2370 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. HARBARTH, K. HOLECKOVA, C. FROIDEVAUX, D. PITTET, B. RICOU, G. E. GRAU, L. VADAS, J. PUGIN, and the Geneva Sepsis Network Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 396 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suzuki, H. Ikezaki, R. Chandiwala, D. Hong, and I. Rubinstein Effects of Pseudomonas aeruginosa endotoxin on vasodilation in the intact spinotrapezius muscle J Appl Physiol, July 1, 2001; 91(1): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Alexander and E. Th. Rietschel Invited review: Bacterial lipopolysaccharides and innate immunity Innate Immunity, June 1, 2001; 7(3): 167 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Fruhbeck, J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrell The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E827 - E847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. OBERHOLZER, A. OBERHOLZER, M. CLARE-SALZLER, and L. L. MOLDAWER Apoptosis in sepsis: a new target for therapeutic exploration |
Article
